Patent · US Active

Kinase inhibitors

US7582652B2 · kind B2 · utility

12Cited by
8References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 25, 2005
Grant dateSep 1, 2009
Priority date
Expiry dateAug 19, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides kinase inhibitors of Formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.